You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
九洲藥業(603456.SH)漲停:與吉利德未就新冠病毒肺炎在研藥物開展實質性合作
格隆匯 02-04 20:55

格隆匯2月4日丨九洲藥業(603456.SH)公佈,公司A股股票於2020年2月3日、2月4日連續兩個交易日收盤價格漲幅偏離值累計達到20%以上,根據《上海證券交易所交易規則》的有關規定,屬於股票交易異常波動。

近日,上證E互動平台有投資者關注公司與吉利德的合作情況,現就相關情況做如下説明:

公司與吉利德於2011年開始合作,公司已為其提供多個品種的醫藥中間體CDMO服務,近兩年,吉利德公司的產品銷售收入佔公司營業收入不超過2%。截止本公告日,雙方未就新型冠狀病毒肺炎在研藥物Remdesivir(瑞德西韋)開展實質性合作,敬請廣大投資者注意投資風險。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account